Duke Team Identifies Blood Biomarkers in Drug-Resistant Cancer Tumor Cells
Duke HealthWhile searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.